DISORDERS, LYMPHOPROLIFERATIVE

Clinical trials for DISORDERS, LYMPHOPROLIFERATIVE explained in plain language.

Never miss a new study

Get alerted when new DISORDERS, LYMPHOPROLIFERATIVE trials appear

Sign up with your email to follow new studies for DISORDERS, LYMPHOPROLIFERATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Immune drug trial offers hope for Tough-to-Treat Virus-Linked cancers

Disease control Recruiting now

This study is testing the drug nivolumab to see if it can slow or stop the growth of certain cancers linked to the Epstein-Barr virus (EBV). It is for people aged 12 and older with EBV-positive lymphomas or lymphoproliferative disorders who have no standard therapy options or who…

Matched conditions: DISORDERS, LYMPHOPROLIFERATIVE

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

DISORDERS, LYMPHOPROLIFERATIVE

Get alerted when new DISORDERS, LYMPHOPROLIFERATIVE trials appear

Immune drug trial offers hope for Tough-to-Treat Virus-Linked cancers